Latest & greatest articles for hepatitis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hepatitis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hepatitis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hepatitis

41. The efficacy of two different dosages of hepatitis B immunoglobulin in interrupting mother-to-infant transmission of hepatitis B virus: a systematic review and meta-analysis

The efficacy of two different dosages of hepatitis B immunoglobulin in interrupting mother-to-infant transmission of hepatitis B virus: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

42. The effect of antiviral treatment discontinued post partum for pregnant women with chronic hepatitis B viral infection: a systematic review and network meta-analysis

The effect of antiviral treatment discontinued post partum for pregnant women with chronic hepatitis B viral infection: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

43. The rate of significant histological disease in immune tolerant phase among people with chronic hepatitis B virus infection: a systematic review and meta-analysis

The rate of significant histological disease in immune tolerant phase among people with chronic hepatitis B virus infection: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

44. The effect of microvascular anastomosis on hepatic artery thrombosis in paediatric liver transplantation: a systematic review and meta-analysis

The effect of microvascular anastomosis on hepatic artery thrombosis in paediatric liver transplantation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

45. Tobacco smoking and hepatitis C virus infection: burden, joint health effects and opportunities for the treatment of both

Tobacco smoking and hepatitis C virus infection: burden, joint health effects and opportunities for the treatment of both Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

46. Systematic review and network analysis: the efficacy and safety of antiviral therapy for hepatitis B infection during different trimesters of pregnancy

Systematic review and network analysis: the efficacy and safety of antiviral therapy for hepatitis B infection during different trimesters of pregnancy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

47. Role of non-invasive assessment of liver fibrosis in predicting liver-related events in chronic viral hepatitis patients: a systematic review and meta-analysis

Role of non-invasive assessment of liver fibrosis in predicting liver-related events in chronic viral hepatitis patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

48. A simplified scoring system for the diagnosis of autoimmune hepatitis: a systematic review and meta-analysis

A simplified scoring system for the diagnosis of autoimmune hepatitis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

49. An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia

An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

50. The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with non-alcoholic fatty liver disease: a systematic review

The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with non-alcoholic fatty liver disease: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

51. Proton pump inhibitor therapy and the risk of hepatic encephalopathy in cirrhotic patients

Proton pump inhibitor therapy and the risk of hepatic encephalopathy in cirrhotic patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

52. Prevalence of tobacco smoking in people living with hepatitis C virus in low-and-middle- in-come and high- income countries: a meta-analysis

Prevalence of tobacco smoking in people living with hepatitis C virus in low-and-middle- in-come and high- income countries: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

53. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a systematic review and meta-analysis

Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

54. The prevalence and prognosis of hepatitis E superinfection in chronic hepatitis B patients: a meta-analysis

The prevalence and prognosis of hepatitis E superinfection in chronic hepatitis B patients: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

55. Efficacy and safety of sofosbuvir plus velpatasvir with or without ribavirin in patients with genotype 3 hepatitis C - a meta-analysis

Efficacy and safety of sofosbuvir plus velpatasvir with or without ribavirin in patients with genotype 3 hepatitis C - a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

56. Treatment for chronic hepatitis E: a systematic review

Treatment for chronic hepatitis E: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

57. The impact of entecavir and tenofovir on the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a systematic review and meta-analysis

The impact of entecavir and tenofovir on the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

58. Systematic review protocol of Influence of models of hepatitis c on anti-HCV activity of medicinal plants

Systematic review protocol of Influence of models of hepatitis c on anti-HCV activity of medicinal plants Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

59. The correlation between hepatitis B core related antigen (HBcrAg) and covalently closed circular DNA (cccDNA): a systematic review and meta-analysis

The correlation between hepatitis B core related antigen (HBcrAg) and covalently closed circular DNA (cccDNA): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

60. Hepatitis B virus in Ethiopia

Hepatitis B virus in Ethiopia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO